Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase theta 3 pseudogene (GSTT3P) is classified as a pseudogene derived from the glutathione S-transferase theta family, specifically related to the theta subclass. Pseudogenes are typically non-functional segments of DNA that resemble functional genes but contain mutations or truncations that prevent them from producing functional proteins. GSTT3P does not encode an active enzyme and, as such, does not perform the canonical catalytic, detoxifying, or other biological activities associated with glutathione S-transferases. It is not recognized as a therapeutic target, and there is no evidence for drug interaction, disease association, or biomarker status. Furthermore, nomenclature or classification confusion exists for GST pseudogenes, and GSTT3P is not included in most curated major gene/target lists, reflecting its status as non-functional.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase theta 3 pseudogene (GSTT3P).